SAMD5 and cholangiocarcinoma: IHC analysis indicated the expression of SAMD5 in human biliary epithelial cells (BECs) and cholangiocarcinoma, where it localizes to the nucleus in cancer cells and the cytoplasm in normal cells, suggesting active nuclear transport in cancer [20].